Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Purifying method for terlipressin

A technology of pure terlipressin, which is applied in the field of polypeptide drugs, can solve the problem of low yield of terlipressin finished products, inability to effectively separate terlipressin, and insufficient purity of terlipressin finished products. Advanced problems, to achieve the effect of low cost and high yield

Active Publication Date: 2014-08-20
ADLAI NORTYE BIOPHARMA CO LTD
View PDF5 Cites 11 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The technical problem to be solved in the present invention is: select a kind of purification method of terlipressin, solve (1) the purity of terlipressin finished product is not high, (2) the yield of terlipressin finished product is not high, ( 3) Terlipressin and impurities [βAsp 8 ]-Terlipressin cannot be effectively separated

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Purifying method for terlipressin
  • Purifying method for terlipressin
  • Purifying method for terlipressin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0088] Solid Phase Synthesis of Terlipressin: Synthesis of Terlipressin on a 10 mmol Scale

[0089] (1) Deprotection of peptide resin: 13.89 g of Rink amide AM resin (substitution degree: 0.72 mmol / g) was added to the solid-phase reaction column, washed once with DMF, and the resin was swollen with DCM for 30 min. The deprotection solution composed of 1:4 piperidine and DMF was reacted for 5 min, washed once with DMF, and reacted with a deprotection solution composed of piperidine and DMF with a volume ratio of 1:4 for 10 min, and washed 6 times with DMF.

[0090] (2) Coupling: 8.92 g Fmoc-Gly-OH (30 mmol) and 4.05 g HOBt (30 mmol) were dissolved in the solvent DMF, the ice bath cooling temperature was 0-10 ℃, and 5 mL DIC (30 mmol) was added, After activating for 5 minutes, add it to the reaction column to react with the deprotected resin. After reacting for 2 hours at 25-35 ℃, use the ninhydrin method to detect and judge the reaction end point. If the resin is colorless and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Mwcoaaaaaaaaaa
Login to View More

Abstract

The invention relates to a purifying method for terlipressin. The method is characterized by comprising the following steps: step 1, dissolving a crude terlipressin product with water and adjusting a pH value to 3 to 4; step 2, flushing a C18 reversed-phase filled column by using an ion pair mobile phase A containing surfactant; step 3, loading a solution obtained in the step 1 into a C18 reversed-phase filling material; step 4, carrying out gradient procedures, wherein the initial-state mobile phase B of an elution gradient is 5% which is maintained for 5 min, then the proportion of the mobile phase B is increased to 30% within 60 min, and a part of target peak elution fraction is collected; and step 5, carrying out nanofiltration membrane desalination and then freeze drying so as to obtain pure terlipressin.

Description

technical field [0001] The invention relates to a purification method of polypeptide drug-terlipressin, which is a purification method with long-acting vasopressin analogs. Background technique [0002] Terlipressin, English name: Terlipressin, is a cyclic polypeptide with the following structural formula: [0003] [0004] The chemical formula is as follows: [0005] . [0006] Terlipressin is a synthetic triglycine-lysine-vasopressin, which is a synthetic vasopressin analogue. It is a prodrug, inactive in itself, and acts on aminopeptidase in vivo. After removing the three glycyl residues at its N-terminus, the active lysine vasopressin is slowly "released", so terlipressin is equivalent to a lysine vasopressin that can release lysine at a steady rate Vegetable storage. The main function of terlipressin is to contract visceral vascular smooth muscle and reduce visceral blood flow (such as reducing the blood flow of mesentery, spleen, uterus, etc.), thereby reducin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K7/16C07K1/20
Inventor 路杨杨东晖周俊周亮
Owner ADLAI NORTYE BIOPHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com